Bipartisan Push for Medicare Coverage of Alzheimer's Blood Tests Gains Momentum
Bipartisan lawmakers introduced the ASAP Act to mandate Medicare coverage for FDA-cleared blood tests that detect Alzheimer's disease early. The legislation aims to bridge a gap between new diagnostic technology and outdated coverage rules, potentially saving billions in long-term care costs. Recent research confirms these blood tests, combined with genetic markers, can predict cognitive decline years before symptoms appear, though current treatments remain expensive and limited.